Variant report
Variant | esv3326463 |
---|---|
Chromosome Location | chr1:56404789-56407792 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:56403818..56405745-chr1:56407271..56408987,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PPAP2B-8 | chr1:56404788-56404953 | NONHSAT003428 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000227104 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4244652 | chr1:56404797-56404798 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs540542905 | chr1:56404834-56404835 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs146355039 | chr1:56404888-56404889 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs532357224 | chr1:56404889-56404890 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs531666921 | chr1:56404895-56404896 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs76672340 | chr1:56404909-56404910 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs6699468 | chr1:56404919-56404920 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs4244653 | chr1:56404927-56404928 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs369806817 | chr1:56404991-56404992 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs6699573 | chr1:56404996-56404997 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs139076122 | chr1:56405023-56405024 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs6699599 | chr1:56405040-56405041 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs570768321 | chr1:56405094-56405095 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539683547 | chr1:56405129-56405130 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs184009751 | chr1:56405160-56405161 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552645180 | chr1:56405167-56405168 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531534997 | chr1:56405172-56405173 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569842106 | chr1:56405175-56405176 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs77401858 | chr1:56405176-56405177 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs555551757 | chr1:56405225-56405226 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs7517205 | chr1:56405234-56405235 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs554078049 | chr1:56405257-56405258 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs577209568 | chr1:56405315-56405316 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs546050640 | chr1:56405358-56405359 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs562660849 | chr1:56405363-56405364 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531496759 | chr1:56405393-56405394 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs143090033 | chr1:56405396-56405397 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548305744 | chr1:56405399-56405400 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs4341397 | chr1:56405400-56405401 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs527289921 | chr1:56405412-56405413 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs6702426 | chr1:56405460-56405461 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs187835993 | chr1:56405471-56405472 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs192319716 | chr1:56405474-56405475 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183033440 | chr1:56405527-56405528 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs147069451 | chr1:56405535-56405536 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs4342888 | chr1:56405548-56405549 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs10630806 | chr1:56405549-56405550 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs34092782 | chr1:56405550-56405551 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs535629048 | chr1:56405564-56405565 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs199908579 | chr1:56405566-56405567 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs4526652 | chr1:56405703-56405704 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs374511721 | chr1:56405732-56405733 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs148026657 | chr1:56405740-56405741 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs7552503 | chr1:56405745-56405746 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs558676780 | chr1:56405765-56405766 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs7552520 | chr1:56405778-56405779 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs368291339 | chr1:56405791-56405792 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs76470507 | chr1:56405798-56405799 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs111247486 | chr1:56405809-56405810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs546137378 | chr1:56405817-56405818 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Papillary thyroid carcinoma | 21436994 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Meckel-Gruber syndrome | 21572526 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 19490664 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:56402000-56416800 | Weak transcription | Aorta | Aorta |
2 | chr1:56403200-56406200 | Enhancers | Fetal Muscle Leg | muscle |
3 | chr1:56403400-56404800 | Enhancers | Stomach Smooth Muscle | stomach |
4 | chr1:56403400-56405000 | Enhancers | Fetal Muscle Trunk | muscle |
5 | chr1:56403400-56405000 | Enhancers | Ovary | ovary |
6 | chr1:56403600-56404800 | Enhancers | Left Ventricle | heart |
7 | chr1:56403600-56404800 | Enhancers | Right Ventricle | heart |
8 | chr1:56403800-56404800 | Enhancers | Colon Smooth Muscle | Colon |
9 | chr1:56403800-56404800 | Enhancers | Fetal Stomach | stomach |
10 | chr1:56403800-56404800 | Enhancers | Right Atrium | heart |
11 | chr1:56404000-56405200 | Enhancers | Fetal Heart | heart |
12 | chr1:56404600-56408600 | Weak transcription | Fetal Lung | lung |
13 | chr1:56404600-56416200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr1:56404800-56409000 | Weak transcription | Colon Smooth Muscle | Colon |